EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RTN2 deficiency results in an autosomal recessive distal motor neuropathy with lower limb spasticity

Reza Maroofian iD, Payam Sarraf, Thomas J O'Brien, Mona Kamel, Arman Cakar iD, Nour Elkhateeb, Tracy Lau, Siddaramappa Jagdish Patil, Christopher J Record iD, Alejandro Horga, Miriam Essid, Laila Selim und 20 weitere

Brain · 2024

DOI: 10.1093/brain/awae091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Reza Maroofian und 31 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK. Hauptthemen laut MEDLINE: Pedigree. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michael J Fox Foundation for Parkinson's Research, Charcot-Marie-Tooth Association, Multiple System Atrophy Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterozygous RTN2 variants have been previously identified in a limited cohort of families affected by autosomal dominant spastic paraplegia (SPG12-OMIM:604805) with a variable age of onset. Nevertheless, the definitive validity of SPG12 remains to be confidently confirmed due to the scarcity of supporting evidence. In this study, we identified and validated seven novel or ultra-rare homozygous loss-of-function RTN2 variants in 14 individuals from seven consanguineous families with distal hereditary motor neuropathy (dHMN) using exome, genome and Sanger sequencing coupled with deep-phenotyping. All affected individuals (seven males and seven females, aged 9–50 years) exhibited weakness in the distal upper and lower limbs, lower limb spasticity and hyperreflexia, with onset in the first decade of life. Nerve conduction studies revealed axonal motor neuropathy with neurogenic changes in the electromyography. Despite a slowly progressive disease course, all patients remained ambulatory over a mean disease duration of 19.71 ± 13.70 years. Characterization of Caenorhabditis elegans RTN2 homologous loss-of-function variants demonstrated morphological and behavioural differences compared with the parental strain. Treatment of the mutant with an endoplasmic/sarcoplasmic reticulum Ca2+ reuptake inhibitor (2,5-di-tert-butylhydroquinone) rescued key phenotypic differences, suggesting a potential therapeutic benefit for RTN2-disorder. Despite RTN2 being an endoplasmic reticulum (ER)-resident membrane shaping protein, our analysis of patient fibroblast cells did not find significant alterations in ER structure or the response to ER stress. Our findings delineate a distinct form of autosomal recessive dHMN with pyramidal features associated with RTN2 deficiency. This phenotype shares similarities with SIGMAR1-related dHMN and Silver-like syndromes, providing valuable insights into the clinical spectrum and potential therapeutic strategies for RTN2-related dHMN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PedigreeHumansMaleFemaleChildAdultAdolescentYoung AdultMiddle AgedAnimalsLower ExtremityCaenorhabditis elegansMuscle SpasticitySpastic Paraplegia, HereditaryMutation

Stichwörter der Autor:innen

dHMNhereditary spastic paraplegianeurodegenerationpolyneuropathy

Autor:innen und Institutionen

  • Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
  • Department of Neuromuscular Diseases, Iranian Centre of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran 1416753955, Iran.
  • Department of Neurology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran 1416753955, Iran.
  • Institute of Clinical Sciences, Imperial College London, London SW7 2AZ, UK.
  • MRC Laboratory of Medical Sciences, London W12 0HS, UK.
  • Department of Pediatrics, Neurology and Metabolic Division, Kasr Alainy Faculty of Medicine, Cairo University, Cairo 4240310, Egypt.

ORCID-Profile: Reza Maroofian, Arman Cakar, Christopher J Record, Alistair T Pagnamenta, Mary M Reilly, Sara Nagy, Henry Houlden

Förderung

  • Michael J Fox Foundation for Parkinson's Research
  • Charcot-Marie-Tooth Association
  • Multiple System Atrophy Trust
  • National Institute for Health Research
  • NINDS NIH HHS
  • Deutsche Forschungsgemeinschaft
  • Wellcome Trust
  • Muscular Dystrophy Association

Zitieren

APA

Maroofian, R., Sarraf, P., O'Brien, T. J., Kamel, M., Cakar, A., Elkhateeb, N., Lau, T., Patil, S. J., Record, C. J., Horga, A., Essid, M., Selim, L., Benrhouma, H., Ben Younes, T., Zifarelli, G., Pagnamenta, A. T., Bauer, P., Khundadze, M., Mirecki, A., …, & Houlden, H. (2024). RTN2 deficiency results in an autosomal recessive distal motor neuropathy with lower limb spasticity. Brain. https://doi.org/10.1093/brain/awae091

Vancouver

Maroofian R, Sarraf P, O'Brien TJ, Kamel M, Cakar A, Elkhateeb N, et al. RTN2 deficiency results in an autosomal recessive distal motor neuropathy with lower limb spasticity. Brain. 2024. doi:10.1093/brain/awae091

BibTeX
@article{Maroofian2024,
  author = {Maroofian, Reza and Sarraf, Payam and O'Brien, Thomas J and Kamel, Mona and Cakar, Arman and Elkhateeb, Nour and Lau, Tracy and Patil, Siddaramappa Jagdish and Record, Christopher J and Horga, Alejandro and Essid, Miriam and Selim, Laila and Benrhouma, Hanene and Ben Younes, Thouraya and Zifarelli, Giovanni and Pagnamenta, Alistair T and Bauer, Peter and Khundadze, Mukhran and Mirecki, Andrea and Kamel, Sara Mahmoud and Elmonem, Mohamed A and Ghayoor Karimiani, Ehsan and Jamshidi, Yalda and Offiah, Amaka C and Rossor, Alexander M and Youssef-Turki, Ilhem Ben and Hübner, Christian A and Munot, Pinki and Reilly, Mary M and Brown, André E X and Nagy, Sara and Houlden, Henry},
  title = {RTN2 deficiency results in an autosomal recessive distal motor neuropathy with lower limb spasticity},
  journal = {Brain},
  year = {2024},
  doi = {10.1093/brain/awae091}
}
Kostenlos starten →